Benefits of Recombinant Zoster Vaccine Outweigh GBS Risk
The small risk of developing Guillain-Barre syndrome (GBS) is outweighed by the advantages of vaccination with the recombinant zoster vaccine to protect against shingles, according to a new study. That research supports the decision by public health officials that the benefit-risk balance remains favorable for the vaccine. Learn more about the results of the study.

Why Recipients Choose One COVID-19 Vaccine Over Another
What is most important in a COVID-19 vaccine to potential recipients? A recent study published in PLOS ONE that involved hypothetical COVID-19 vaccines not only answers that question but also finds key differences in the views of those who plan to be vaccinated compared with those who are hesitant to get the shots. Learn more about the results of the study.

Invasive Pneumococcal Disease Increasing in Older U.S. Adults
While the introduction of pneumococcal conjugate vaccines into the infant immunization schedule about 20 years ago reduced cases of antibiotic-nonsusceptible invasive pneumococcal disease in most age groups, it continues to be a problem in older adults. Find out what the authors of a study published in the Journal of Infectious Diseases propose as a solution.